BI
JAZZ icon

Binnacle Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Binnacle Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.99K Buy
53
+48
+960% +$5.76K ﹤0.01% 477
2025
Q2 		$531 Hold
5
– – ﹤0.01% 767
2025
Q1 		$621 Buy
+5
New +$652 ﹤0.01% 669

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Binnacle Investments's JAZZ Position: Q3 2025 in Review

Binnacle Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 960% in Q3 2025, buying an estimated $5.76K and bringing the position to 53 shares worth $6.99K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Binnacle Investments first reported a position in JAZZ in Q1 2025 and has held it in 3 quarters since. 502 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Binnacle Investments held 53 shares of Jazz Pharmaceuticals worth $6.99K as of Q3 2025.
  • Binnacle Investments bought 48 Jazz Pharmaceuticals shares in Q3 2025, an estimated $5.76K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #477 holding.
  • Binnacle Investments first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.